Visken 5mg tablets

Χώρα: Ηνωμένο Βασίλειο

Γλώσσα: Αγγλικά

Πηγή: MHRA (Medicines & Healthcare Products Regulatory Agency)

Δραστική ουσία:

Pindolol

Διαθέσιμο από:

Advanz Pharma

Φαρμακολογική κατηγορία (ATC):

C07AA03

INN (Διεθνής Όνομα):

Pindolol

Δοσολογία:

5mg

Φαρμακοτεχνική μορφή:

Oral tablet

Οδός χορήγησης:

Oral

Kατηγορία:

No Controlled Drug Status

Τρόπος διάθεσης:

Valid as a prescribable product

Περίληψη προϊόντος:

BNF: 02040000; GTIN: 5060064170458

Αρχείο Π.Χ.Π.

VISKEN TABLETS 5 MG
Summary of Product Characteristics Updated 02-Jan-2014 | Concordia
International - formerly AMCo
1. Name of the medicinal product
Visken 5 mg Tablets
Pindolol 5mg Tablets
2. Qualitative and quantitative composition
Each tablet contains 5 mg Pindolol.
3. Pharmaceutical form
Tablet.
4. Clinical particulars
4.1 Therapeutic indications
_Essential hypertension: _For reduction in blood pressure in essential
hypertension. Onset of action of this
medicine is usually rapid, most patients showing a response within the
first one to two weeks of
treatment. However, maximum response may take several weeks to
develop.
_Prophylactic treatment of angina pectoris: _Prophylactic treatment
with this medicine reduces the
frequency and severity of anginal attacks and increases work capacity.
4.2 Posology and method of administration
Adults
_Hypertension: _Initially one 5 mg tablet two or three times a day.
According to the response of the patient
the dose may be increased at weekly intervals to a maximum of 45 mg
given in divided doses twice or
three times daily.
_Once daily dosage schedule: _Further work shows that many patients
respond to a once daily dosage
regime. Initially 15 mg (3 tablets) should be taken once a day with
breakfast and adjusted according to
individual response up to a maximum of 45 mg (9 tablets). Most
patients respond to a once daily dose of
between 15-30 mg (3-6 tablets).
_Angina pectoris: _Usually 2.5 mg to 5 mg orally three times a day
according to response.
Use in children
Experience with this medicine in children is limited. Its use is
therefore not recommended.
Use in the elderly
No evidence exists that elderly patients require different dosages or
show different side-effects from
younger patients.
Route of administration
Oral.
4.3 Contraindications
Untreated cardiac failure, cardiogenic shock, sick sinus syndrome,
second and third degree heart block,
Prinzmetals angina, history of bronchospasm and bronchial asthma (a
warning stating "do not take this
medicine if you have a history of